ArrantaBio is a CDMO that markets itself as a strategic partner for innovative biotech companies. The company is seeking to lead the microbiome sector through process and analytical innovation and quality-by-design. The company has plasmid, mRNA, and LNP capabilities seeking to service innovative companies.